At a glance
ClinicalIndex Comparison RecordN/ACompleted· 57 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Demographic and Laboratory Data Collection for Patients With Vitiligo Vulgaris
In Brief
An observational study for Vitiligo Vulgaris. Completed, enrolled 57 participants across 2 sites.
Detailed Summary
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVitiligo Vulgaris
CountriesUnited States
CollaboratorsBeth Israel Medical Center
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedSep 2010
Primary CompletionOct 2010
Study CompletionSep 2014
TodayJul 2026
First PostedSep 21, 2010
Enrollment StartAug 1, 2010
Primary CompletionOct 1, 2010
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.8 years ago